This manual describes some of the strategic, managerial, financial, technical and scientific aspects to be considered in establishing a national EQA programme for clinical laboratories and other testing services at all health care levels
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV).
This document provides information and recommendations for action, based on the current available knowledge around monkeypox. It is a first draft which will be updated in light of evolving evidence and additional information as they become available.
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
Ebola Virus Disease Outbreak Response Plan in West Africa. Annex 2
of highly contagious viruses (of the Ebola or Marburg type) in the context of an epidemic outbreak in West Africa
Interim Recommendation published 19 September 2014. These recommendations reflect current understanding of Ebola virus disease (EVD) and are intended for national laboratory staff performing diagnostic testing to detect Ebola virus.
PQDx 0006-005-00 WHO
PQDx PR
February/2016, version 2.0
This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member States. The algorithm is not intended for clinical man...agement of patients with suspected Zika virus infection.
The information is provisional and subject to revision when new information becomes available.
more
Guidelines for Handling Temperature Sensitive Vaccines and Pharmaceuticals